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Abstract
Background: Mannoproteins are yeast cell wall componend, and rich in mannose. The use of foods rich in mannose as 
carbohydrate, could have a bioprotective effect against entrobacteria intestinal infection. Nothing is known about 
mannoproteins' activity in inflammatory bowel processes induced by entrobacteria.
This study investigates the effects of mannoprotein administration via a liquid diet on inflammatory response and TLR5
expression during intestinal tissue injury in a rat model of infection with Salmonella typhimurium.
Methods: Adult Wistar male rats were divided into three groups: control, and mannoprotein E1 at 10 or 15%. Animals 
were fed with a liquid diet supplemented or not with mannoprotein E1. Groups were infected by intragastrical 
administration of S. typhimurium. 24 h post-inoculation samples of spleen, ileum and liver were collected for 
microbiological studies. Gut samples were processed to determine levels of proinflammatory cytokines (mRNA) and 
TLR5 (mRNA and protein) by quantitative PCR and Western-blot, and the number of proliferative and apoptotic cells 
determined by immunohistochemistry.
Results: Ininfected levels of proinflammatory cytokines and TLR5 were higher in untreated controls than in the animals 
receiving mannoprotein. Proliferation was similar in both groups, whereas apoptosis was higher in controls. Curiosly, 
the mannoprotein effect was dose dependent.
Conclusions: Mannoprotein administration in a liquid diet seems to protect intestinal tissue against S. typhimurium 
infection. This protection seems to expressed as a lower pro-inflammatory response and TLR5 downregulation in gut 
epithelium, as well as by an inhibition of apoptosis. Nevertheless, the molecular mechanism by which mannoprotein is 
able to regulate these responses remain unclear. These results could open up new avenues in the use of 
mannoproteins as prebiotics in the therapeutic strategy for treatment of inflammatory gut processes induced by 
microbia.
Background
GRAM-NEGATIVE BACTERIA of the Salmonella enter-
iditis group are common human pathogens and often iso-
lated from cases of acute food-borne gastroenteritis in
developing countries as well as the United States and
Europe [1]. S. enteriditis interaction with the intestinal
epithelia triggers secretion of chemokines and cytokines
and the subsequent luminal translocation of neutrophils
[2]. The result of this inflammatory response is clinically
correlated with acute diarrhea.
Intestinal epithelium is considered an integral and
essential component of the innate mucosal immune sys-
tem [3]. Intestinal epithelial cells (IECs) can respond to
enteric pathogens (e.g. Salmonella species, Yersinia
enterocolitica, and enteropathogenic Escherichia coli)
either by the release of molecules directly endowed with
bactericidal properties [4] or by the secretion of pro-
inflammatory mediators [5-8] and the expression of
adhesion molecules [9], which permit the recruitment of
immune cells and induction of a protective inflammatory
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response that can eradicate pathogens. Many studies have
demonstrated that the response by mammalian cells to
pathogens is orchestrated through the activation of the
nuclear transcription factor κB (NF-κB) [10,11] following
cell receptor recognition of specific prokaryote motifs
called PAMPs (pathogenic associated molecular pat-
terns). Toll-like receptors (TLRs), some of which are
expressed by enterocytes, are the best-characterized fam-
ily of mammalian PAMPs receptors [12]. TLRs recognize
an array of prokaryote motifs, including unmethylated
CpG DNA motifs, lipopolysaccharides (LPS), lipopro-
teins, peptidoglycan, and flagellin [12,14], that are shared
by both pathogenic and commensal bacteria, suggesting
that either type of bacteria may have the potential to initi-
ate innate immune host responses in IECs. Flagellin is a
bacterial product that is generally considered a PAMP,
with TLR5 as its physiological receptor in vertebrates
[15]. In S. typhimurium, bacterial motilility depends on
an extracellular filament structure with 20,000 subunits.
Purified flagellin can activate transcription and secretion
of the proinflammatory chemokine IL-8 in cell culture
systems [16]. Flagellin is also a potent activator of sys-
temic inflammation in murine models [17], and, in
humans, serum levels of this protein correlate with clini-
cal severity in bacteremic shock syndromes [18], and this
indicates a role for this bacterial protein in the immunop-
athogenesis of inflammatory bowel disease [19]. Interest-
ingly, recent studies indicate that flagellin is able to
activate apoptotic signaling pathways. This activation is
parallel to a classical proinflammatory pathway and may
be a general feature of innate immunity activators of so
flagellin may play a previously underappreciated role in
host monitoring of, and response to, microbes [20].
Mannoproteins are components of the yeast cell wall;
they are 90% carbohydrate and phosphodiester bonds
between lateral manose residue and are widely used for
improving the foaming properties in sparkling wines [21].
Mannoproteins are mainly N- and O- glycosilate proteins
with a highly polymerized and branched glucosilade frac-
tion, with around 150 and 200 mannose residues [22]. It
has recentlybeen demonstrated that food supplementa-
tion with mannoprotein inhibits gut colonization by Sal-
monella and other gut bacteria in animals [23-25]. The
use of foods rich in manose as carbohydrate in the diet
could have a bioprotective effect against intestinal infec-
tion caused by entrobacteria [26-28]. Nevertheless, little
is known about its iinvolvement in bowel inflammatory
processes induced by microbes. Therefore, several clini-
cal studies have been conducted with Saccharomyces
boulardii, a yeast species, in the treatment and preven-
tion of various forms of diarrhea, proving it a promising
research perspective in the therapy of inflammatory
bowel disease [29].
In this manuscript we evaluate the action of a yeast cell
wall fraction called "mannoprotein" added to a liquid diet
in a rat model of salmonella infection by analyzing the
induction of proinflammatory cytokines, and, whether
mannoprotein can affect hostexpression of the flagelin
receptor TLR5, which is induced by Salmonella.
Methods
Animals
82 adult Wistar male rats were included in this study and
divided in three groups depending on diets: controls (n =
24) and mannoprotein enriched (n = 58) divided by man-
noprotein level (n = 28 at 10% and n = 30 at 15%). Healthy
animals came from (Harlan S.A, Spain). and were housed
in the Experimental Surgery facilities of La Paz Hospital,
in compliance withSpanish law on the protection of
experimental animals (RD 1201/2005). All procedures
were approved by HULP Animal Care Committee.
Diets
Animals were caged individually throughout the experi-
ment with free access to. liquid diet (Dietgriff® ; 1 Kcal/ml,
16% Protein, 29% fat, Lipid and 55% Glucides) was sup-
plemented either with 10% and 15% mannoprotein E1
(BIOMOS Alltech, Inc), mannoprotein a rich product
from Saccharomyces cerevisiae, the resulting product was
isocaloric, prepared daily and administered during 4
days. Previously different percentages (2%, 5%, 10%, 15%)
of mannoprotein has been tested to identify the best per-
centages at which the mannoprotein injected against Sal-
monella colonization.
Intragastric in vivo inoculation
Salmonella tiphymurium (ATCC 14028) were grown stat-
ically to 3 × 108 ufc/ml ( Macfarlan) and sequentially
diluted to 103 ufc/ml. This concentration was the min-
imun needed to produce infection in the animals and to
find differences between controls and mannoprotein
treated animals using 10% a 15% mannoprotein diet.
After four days mannoprotein administration rats were
anesthetized with isofluorane (2%) and innoculated with
1ml (103 ufc/ml) of the salmonella culture in bicarbon-
ated serum saline (30 gr/l) by intragastric catheter [30-
32].
Tissue Sampling
24 hours after innoculation, animals were killed by
sodium phentobarbital i. p. administration (50 mg/Kg).
Spleen, liver and ileum were collected for microbiological
studies [30-32]. Samples were homogenized in sodium
saline and/placed/in an Agar - Salmonella Shigella and
Selenitum enriched medium. Colony identification was
made its morphological characteristics and agglutinationPosadas et al. BMC Gastroenterology 2010, 10:58
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with specific anti-sera to Salmonella poly A and S. typh-
imurium (Difco).
Samples from the ileum, jejunum and colon were taken
and placed in 10% neutral buffered formalin during 24 hr
for Q-PCR and Western-blot assay. Fixed ileum was
embedded in paraffin blocks, from which 5-μm serial sec-
tions were cut for immunohistochemical studies.
Quantification of TLR-5, IL-1β, IL-6 and TNF-α mRNA 
expression. Real time PCR
Expression levels of TLR-5, IL-1β, IL-6 and TNF-α were
detected by real time PCR (LightCycler, Roche Diagnos-
tics, Indianapolis, USA). cDNA from 1 μg of total RNA
was used for PCR. Real-time PCR was performed with
the Fast-Start DNA master SYBR Green system (Roche).
The sequences of the primers are as follows:
S26-f: 5' ATGCGTGCCCAAGGACAAGG 3',
S26-r: 5'GGCAGCACCCGCAGGTCTAA 3';
IL-1beta-f: 5'AACAGCAATGGTCGGGACAT 3',
IL-1beta-r: 5'GCATTAGGAATAGTGCAGCCATCT 3';
IL-6 -f: 5'TACCCCAACTTCCAATGCTC3'
IL-6-r: 5' TGGACATTCCTCACTGTGGT 3';
TNF-α-f: 5'CACGTCGTAGCAAACC3'
TNF-α-r: 5'GGTGAGGAGCACATAGT3';
TLR-5-f:5' TGTCAACAGGGTGCTTTGTC 3'
TLR-5-r: 5'AAAAGCAGGTGGCTTGAGAA 3'
All results were normalized with respect to the expres-
sion of S26. a rhibosomal protein.
The cDNA copy number for each gene of interest was
determined using a seven-point standard curve. Standard
cu rves w e r e  run wit h ea ch set  o f  sa m p les.  C o rr e la t ion
coefficients (r2) for standard curves were typically ≥ 0.98.
The precision of target S26 from the same cDNA was-
quite good, as was the day to day reproducibility. To con-
firm that each primer pair correctly amplified the
sequence of interest, initial PCR products from tissue
were run on agarose gel, stained with 0.5 μg/ml ethidium
bromide, and viewed by UV transillumination to confirm
that a single product of the predicted size was produced.
To confirm the specificity of the reaction product during
each run, the melting profile of each sample was analyzed
using the LightCycler. The melting profile was deter-
mined by holding the reaction at 80°C for 10 s and then
slowly heating to 95°C with a linear rate of 0.1°C/s while
measuring the emitted fluorescence. Melting curve analy-
sis demonstrated that each of the primer pairs described
amplified a single product. The rare samples that demon-
strated a significant second peak in the melting profile
were not used in analysis.
TLR-5 Western-Blot
To demonstrate potential changes in TLR5 expression,
western blotting was performed on total protein samples
isolated from jejune, ileon and colon tissues using RNA-
DNA-protein separation reagent (Progen Industries,
Brisbane, Australia). First, the protein concentration was
quantified using Bradford reagent (Sigma, St. Louis MO)
with BSA as a standard. Equal amounts of protein (10 μg)
from each sample, and 2 μg of biotinylated broad range
protein molecular weight markers (Bio-Rad, Hercules,
CA) were treated with a reducing sample buffer; samples
were then separated on a 12.5% SDS-PAGE minigel, and
electroblotted onto 0.2-μm nitrocellulose membranes
(Amersham) (100 V, 500 mA, 4°C, 40 min). Membranes
were blocked for 2h in 5% bovine serum albumin (BSA)
and then incubated overnight with a rabbit TLR5 poly-
clonal IgG antibody (Santa Cruz Inc., USA) at a concen-
tration of 1:750. After primary antibody incubation,
membranes were washed 5x10 min in tris (hydroxym-
ethyl) aminomethane-buffered saline (TBS), with the
third 10-min washing in TBS with 0.05% Tween-20, and
then incubated for 1 h at 4°C with a 1:10.000 dilution of
peroxidase-conjugated swine anti-rabbit biotinylated IgG
and avidin/biotinylated horseradish peroxidase reagents
(Dako). Membranes were then washed for 5x10 min in
TBS, followed by a 60-s wash in enhanced chemilumines-
cence reagents (Amersham). High-performance lumines-
cence detection film (ECL-PLUS, Amersham, Sweeden)
was exposed to membranes in a film cassette for between
10s and 2 min and developed. Western-blot of β-tubuline
was used as an internal control.
Apoptosis and proliferation assay: Immunostaining
To analyze any potential site-specific changes in the
member of either apoptotic or proliferative positive cells
in the Ileum samples in the two groups examined, immu-
nohistochemical detection of Ki-67 antigen or TUNEL
were performed on paraffin sections of the ileum. The ki-
67 was detected as follows: After removal of paraffin with
xylene, by endogenous peroxidase blocking in all tissues
with 3% H2O2 in methanol. All tissue sections were pre-
treated in a microwave oven in citrate buffer at pH 6.0 for
10 minutes at 300 W. Unspecific binding sites were
blocked using washing buffer 1 (no. K5006; DAKO,
Glostrup, Denmark) before incubation with the primary
antibody. Slides were incubated for 1 hour at room tem-
perature with the primary antibodies. As primary anti-
bodies, we used monoclonal antibody MIB-5 (antibody
concentration 0.2 mg/ml, no. 2093; Immunotech, Mar-
seille, France. To avoid background due to secondary
antibody binding to mouse immunoglobulins in the tis-
sue, MIB-5 was biotinylated using the Animal Research
Kit Peroxidase (no. K3954; DAKO) according to the man-
ufacturer's instructions before immunostaining. As a
detection system, a streptavidin-peroxidase complex
included in the kit was used with a 3.3'-diaminobecidine
(DAB) substrate (Sigma). A normal rabbit serum was
used as a negative control. For TUNEL: Five-μm sections
of formalin-fixed, paraffin-embedded renal tissue were
dewaxed, rehydrated, washed in PBS, and incubated inPosadas et al. BMC Gastroenterology 2010, 10:58
http://www.biomedcentral.com/1471-230X/10/58
Page 4 of 12
terminal deoxynucleotidyl transferase (TdT) buffer for 10
min at room temperature before incubation with TdT
enzyme (Promega, Madison, WI) and digoxigenin-
labeled dUTP (Boehringer Mannheim, Mannheim, Ger-
many) for 1 h at 37°C. After the sections were washed in
PBS, a sheep anti-digoxigenin F(ab)2 was applied for 1 h at
room temperature. Endogenous peroxidase was blocked,
and a peroxidase-conjugated rabbit anti-sheep antibody
was applied followed by a peroxidase-conjugated swine
anti-rabbit antibody. The reaction was developed with
the use of a Pierce metal-enhanced diaminobenzidine
substrate (Rockford, IL). On the basis of terminal deoxy-
nucleotidyl transferase mediated dUTP nick end labeling
(TUNEL) staining and morphologic changes, the apop-
totic cells were counted under light microscope in 50
glomerular cross sections and 10 random areas of 0.15
mm2 in the interstitium, with the use of a grid at 400x
magnification. Negative controls without TdT enzyme
and positive controls with DNase treatment were
included for each tissue. No paraffin-embedded tissues of
the PAN model were available to assess apoptosis by
TUNEL technique at week 17.
Statistical analysis
Results of degree of infection, Q-PCR (cytokine and
TLR5 gene expression), Western-blot (TLR5 protein lev-
els) and immunohistochemistry (number of ki-67 antigen
and apoptotic positive cells) in the different groups were
compared with one-way ANOVA.
Results
Results of microbiological study
24 hours after Salmonella inoculation (103 ucf/ml), 9/24
(37.5%) of the animals in the control group were infected
in at least one of the tissues analyzed in the microbiologi-
cal analysis. Nevertheless, in the animals treated with
10% mannoprotein E1 the infection rate was lower 8/28
(28.6%), moreover the animals treated with 15% manno-
protein E1 showed an even lower infection rate --3/30
(10%)-- and only one tissue type was infected in 11 of the
58 mannoprotein-treated animals. Interestingly, the Sal-
monella dosis was optimized to 103 ucf/ml, the level at
which there were differences between groups treated
with mannoprotein. The first comparison of infection
levels between two groups (controls and 10% mannopro-
tein E1) was statistically non significant with a p < 0.54
and a difference of 8.9%, meaning that although manno-
protein had reduced infection, the decrease was not sig-
nificant. Comparing controls with rats receiving 15%
mannoprotein E1 showed significant differences in infec-
tion rate (p < 0.05), as the percedntage of infected animals
(intestinal colonization) was reduced by 27.5%, thus indi-
cating a dose dependency (difference control vs 10% vs
15%). Interestingly, infection was found in one or more
tissues in the control group animals, whereas in the man-
noprotein groups, no animal had infection in more than
one tissues type, and in all cases the infection was limited
to the ileum homogenates, which necessarily included
material from the lumen. Notably, when we evaluated
bacterial translocation (regional and/or systemic levels),
mannoprotein resulted in a significant decrease from
intestinal lumen (local level) to liver and spleen since 44%
of controls showed translocation, and 0% of either of the
10% and 15%. mannoprotein treated groups showed
infection beyond the local level.
Table 1 shows the results in percentages of the degree
of infection and number of tissues affected in all study
groups.
Tissue was taken from the Salmonella infected rats for
molecular biology and immunohistochemistry study
(control, n = 9; mannoprotein 10% E1, n = 8). The num-
ber of infected rats (n = 3, 10%) in the Manoprotein 15%
E1 group was too low to allow statistically significant
analysis and so were not included in the following studies.
Analysis of mRNA expression of IL-6, TNF-alpha, IL-1beta 
and TLR5 in ileal, colon and jejunum samples
Proinflammatory cytokines and TLR5 were determined
by quantitative RT-PCR analysis, which measured the
changes in gene transcription. Changes were significant
at the mRNA level in intestinal ileum, colon and jejunum
mucosa.,.
mRNA expression in jejunum
Figures 1A,B,C and 1D illustrate the results for IL-6,
TNF-alpha, IL-1beta and TLR5 levels respectively as a
ratio of mRNA expression compared with the expression
Table 1: Results of microbiological study
Group N % infected Rats % of infected rats with ≥ 2 
organs affected
% of infected rats with 1 organ 
affected
Control 24 37.5 (N = 9) 44.4% of 37.5% (N = 4) 55.6% of 37.5% (N = 5)
Mannoprotein 10% E1 28 28.6 (N = 8) 0% 100%(N = 8)
Mannoprotein 15% E1 30 10% (N = 3) 0% 100% (N = 3)Posadas et al. BMC Gastroenterology 2010, 10:58
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of the S26 gene, which was employed as a housekeeping
gene. IL-6 levels were higher in the control group than in
the mannoprotein-treated animals (p = 0.001; figure 1A).
Levels of TNF-alpha and IL-1beta were also higher in the
control group than the mannoprotein treated animal
group (p = 0.001) in both analyses. Levels of TLR5 mRNA
expression also differed significantly between groups (p <
0.001, figure 1D).
mRNA expression in Ileum
As in the jejunum, IL-6, TNF-alpha and IL-1beta levels
were also higher in the control group than in the manno-
protein treated group (P < 0.001) (figures 2A,B and 2C).
However, TLR5 mRNA expression levels showed no dif-
ferences between the two groups (figure 2D).
mRNA expression in Colon
Proinflammatory cytokine mRNA expression and TLR5
levels were similar in colon to levels in jejunum with the
controls showing higher IL-6 levels than the mannoppro-
tein-treated animals (P < 0.001; figure 3A). TNF-alpha
and IL-1beta levels were higher in the control group than
the mannoprotein-treated group (P < 0.001) in both anal-
yses (figure 3B and 3C). TLR5 gene transcription levels
also showed statistical differences between the two
groups. P < 0.001; figure 3D.
Protein levels of TLR5 in jejunum, Ileum and Colon
The results of TLR5 protein expression showed higher
levels in the control group than the mannoprotein-
treated group in the three tissues studied (figure 4). TLR5
levels were similar in jejunum, Ileum and colon in the
controls. The greatest significant differences between
groups were found in the Ileum (p < 0.009, figure 4B).
However, the differences in TLR5 expression levels in
jejunum and colon seem to be similar in all groups (p <
0.05, figure 4A and 4C). Figure 4D illustrates a represen-
tative picture of TLR5 and beta-tubuline Western-Blot
result for both groups in jejunum and Ileum.
Figure 1 Quantification of IL-6, TNF-α, IL-1β and TLR5 mRNA in jejune samples. Figure 1A and 1B illustrate in a bar diagrams that IL-6 and TNF-
α mRNA expression increased markedly in control group compared with mannoprotein. Figure 1C shows IL-1β mRNA expression in both groups rep-
resented as bars diagram (n = 9 control group, n = 8 mannoprotein group). No statistical differences were observed between both groups. Finally, 
figure 1D shows the results for TLR5 gene expression in both groups with augmented levels in the control group compared with mannoprotein. Error 
bars represent the standard deviations. * Significant at p > 0.05 compared with control.Posadas et al. BMC Gastroenterology 2010, 10:58
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Immunohistochemical findings
Results on proliferation and apoptosis
Apical Ki-67 antigen immunohistochemistry in the intes-
tinal Ileum and colon crypts and villi
The data showed insignificant differences in the num-
ber of Ki-67 positive cells in the different study groups.
Positive cell staining for proliferation was found mainly in
the central villi and crypts. The bar diagram in figure 5 A
illustrates the results in number of positive cells per villi
for both the control and the mannoprotein treated
groups. Figure 5B shows a representative picture of tissue
and positive staining (arrows) for each group.
Regarding apoptosis immunoreactivity, our data
showed significant differences between the two groups (p
< 0.001). Interestingly, apical immunoreactiviy showed an
increase in the control group compared to the manno-
protein treated group - see figure 6A. These results are
expressed in a bar diagram indicating number of positive
cells per villus. Figure 6B shows a representative picture
of tissue and positive staining (arrows) for each group.
Discussion
Recent molecular-based investigations have confirmed
the species diversity and metabolic complexity of human
microbiota. It is also increasingly clear that human gut
microbiota have a crucial impact on host health, both as a
source of infection and environmental insult and, con-
versely, as protection against disease by maintaining gut
function. Thus, investigators are beginning to develop
microbiota management employing by probiotics and
prebiotics, including mannoprotein [33]. Nevertheless,
little information is available in the literature to analyze
the effects in the gut of the molecular components of pro-
prebiotics during a bacterial infection. This manuscript
evaluates the effects of mannoprotein, a component of
the yeast cell wall, in a rat model of Salmonella infection.
Figure 2 Quantification of IL-6, TNF-α, IL-1β and TLR5 mRNA in Ileum samples. Figure 2A and 2B illustrate in a bar diagram that IL-6 and TNF-α 
mRNA expression increased markedly in control group compared with mannoprotein(n = 9 control group, n = 8 mannoprotein group). Figure 2C 
shows IL-1β mRNA expression in both groups represented as a bar diagram, with higher and significant levels in the controls. Finally, figure 2D shows 
the results for TLR5 gene expression in both groups with no differences in the control group compared with mannoprotein. Error bars represent the 
standard deviations. * Significant at p < 0.05 compared with control.Posadas et al. BMC Gastroenterology 2010, 10:58
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Microbiological analysis revealed a protective effect by
these compounds that decreased the number of animals
infected and the number of organs (spleen, liver and gut)
invaded by the infection. Furthermore, at a molecular
level, the infected animals treated with mannoprotein
showed a lower pro-inflammatory response than the
untreated infected control animals, which did not receive
mannoprotein.
It is generally assumed that an intestinal proinflamma-
tory mechanism is a characteristic response to patho-
genic intestinal bacteria, whereas the commensal bacteria
should not induce this response, which interrupt the
symbiosis between the bacteria and their mammalian
host. Epithelial cells lining the gut have recently been
identified as key players in the regulation of the initial
steps of host proinflammatory responses to intraluminal
bacteria via their controlled expression of PAMP recep-
tors. One attractive hypothesis is that intestinal epithelial
cells are hyporesponsive to commensal intraluminal bac-
teria because of the low PAMP receptor number on the
apical surface on the epithelial cells [22], whereas invasive
bacteria have access to, and can activate, PAMP receptors
in the intracellular space or on the basolateral membrane.
In support of the hypothesis, our study shows that man-
noproteins apparently modulate the proinflammatory
response either because they form a physical barrier to
the Salmonella infection or they disrupt the interaction
r e q u i r e d  f o r  a c t i v a t i o n  o f  N F - κ B  a t  a  g i v e n  m o l e c u l a r
level, thus blocking further signalling cascades beyond
that level. Induction of the NF-κB pathway relies on the
interaction of flagellin, which is common to all flagellated
bacteria, with the TLR5 expressed in situ in the ileum, in
both the basal and apical compartments of the epithelial
cells and enterocytes. In fact, mannoproteins inhibited
campylobacter adherence and invasion of Caco-2 cells in
a recent in vitro study [34]. Thus, mannoproteins would
Figure 3 Quantification of IL-6, TNF-α, IL-1β and TLR5 mRNA in colon samples. Figure 3A and 3B illustrate in a bar diagram that IL-6 and TNF-α 
mRNA expression increased markedly in control group compared with mannoprotein (n = 9 control group, n = 8 mannoprotein group). Figure 3C 
shows IL-1β mRNA expression in both groups represented as a bar diagram. No statistical differences were observed between both groups. Finally 
figure 3D shows the results for TLR5 gene expression in both groups with augmented levels in the control group compared with mannoprotein. Error 
bars represent the standard deviations. * Significant at p < 0.05 compared with control.Posadas et al. BMC Gastroenterology 2010, 10:58
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seem good candidates to protect against infection
through an intestinal route.
In our study, an inflammatory cytokine response was
induced in the gut of the rats after oral infection with
small amounts of a Salmonella typhimurium innoculus.
In our experiments the control group showed higher
TNF-α and IL-6 mRNA expression than the mannopro-
tein-treated rats. This phenomenon was observed in the
three tissues analyzed: jejunum, ileum and colon. IL-1β
mRNA expression was only affected in the Ileum of con-
trol rats, which showed higher expression levels than
treated animals. This response agrees with previous stud-
ies in murine small intestine, in which both IL-6 and
TNF-α were induced after exposure to S. typhimurium
[35-38]. IL-1β mRNA synthesis is increased in intestinal
epithelial cells after Salmonella infection [36]. In contrast
to the other cytokines studied, IL-1β enhances the innate
response by activating NF-κB [39,40]. We observed a
clear action by mannoprotein on proinflammatory
cytokine mRNA expression since these levels were lower
in the treated animals than the controls. This suggests an
anti-inflammatory effect whereby mannoprotein could be
involved in some protective mechanisms against oral
infection by Samonella typhimurium.
Our study also measured the expression of TLR5, the
specific  Salmonella typhimurium flagellin receptor, at
both mRNA and protein levels. Our results demonstrated
decreased levels of gene and protein expression in the
mannoprotein treated group. Thus, mannoprotein itself
is able to regulate TLR5 expression after infection by Sal-
monella. No data are available in the literature about this
regulation, but there are recent studies on TLR5/flagellin
interaction and the activation cascades involved in this
process. These signaling cascades activate the NF-κB
pathway and induce a proinflammatory response that
mediates up-regulation of cytokines, chemokines and
Figure 4 Quantification of TLR5 protein levels in yeyune, Ileum and colon samples., Figure 4A, 4B and 4C show the levels of TLR5 protein ex-
pression in both groups for yeyune, ileum and colon respectively. In all figures an augmented expression of TLR5 is observed in the control group 
compared with mannoprotein (n = 9 control group, n = 8 mannoprotein group). These differences were statistically significant. Figure 4D shows a 
representative Western-blot picture of TLR5 and β-tubuline in yeyune (left) and Ileum (right) for both groups controls (designed as C) and mannopro-
tein (designed as M). Error bars represent the standard deviations. * Significant at p < 0.05 compared with control.Posadas et al. BMC Gastroenterology 2010, 10:58
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adhesion molecules, etc. Protein modifiers of cellular
apoptotic pathways are integral components of this
response. This observation strongly supports the notion
that apoptotic activation proceeds in parallel with proin-
flammatory activation [41-43]. Concerning the inflam-
matory response in our results, the decreased TLR5 levels
of in the mannoprotein group could explain the lower
levels of IL-1β, TNF-α and IL-6 mRNA expression found
in treated rats compared to their controls.
The crypt proliferative cells and apical and central
apoptotic cells of the villi were immunohistochemically
analysed in order to establish a possible effect of manno-
protein in proliferative and apoptotic response in Ileal tis-
sue. Interestingly, the number of apoptotic cells in the
control group was significantly higher than in the manno-
protein group. Nevertheless, when we analyzed the pro-
liferative response in tissue these were no differences
between the groups. This could be explained by the fact
that the highest levels of TLR5 were found in the control
group where they possibly activated both the pro-inflam-
matory and the apoptotic pathways as suggested in a
recent study where both pathways were activated the
inappropriate location of flagellin [25]. We cannot con-
firm this possibility, although it seems likely, because we
did not determine flagellin levels or position in our study.
Furthermore, other in vitro studies have indicated that
Salmonella provokes apoptosis in macrophages [44,45]
and in HT-29 epithelial cells after 24 hours of co-culture
[46]. On a different level a recent study with chickens,
reports that mannoprotein diet enrichment increased
jejunal villus height and thymal weight, changes that
could point to an increased immune response capacity
and improved gut function [47]. Summarising, the
administration of mannoprotein could exert a protective
effect by inhibiting the apoptosis induced by oral infec-
tion with Salmonella.
In conclusion, Mannoprotein administration in a liquid
diet seems to protect the intestinal tissue against the
effects of Salmonella triphymorium. This protection
seems to be effected by down regulation of the proinflam-
matory response and of TLR5 expression, in addition to
the inhibition of apoptosis. Nevertheless, the molecular
Figure 5 Number of total proliferative immunoreactive cells in ileum crypts and villi. Figure 5A shows the number of total proliferative positive 
cells in both groups analyzed as a bar diagram. Non statistical differences were found between controls and mannoprotein group. Figure 5B shows 
immunohistochemical location of proliferative cells in Ileum crypt in control. Figure 5C shows immunohistochemical location of proliferative cells in 
crypt villi in mannoprotein. Arrows indicate proliferative positive cells predominantly located in central villi and crypta. Photomicrographs at original 
magnification 20x. Error bars represent the standard deviations. * Significant at p < 0.05 compared with control group.Posadas et al. BMC Gastroenterology 2010, 10:58
http://www.biomedcentral.com/1471-230X/10/58
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mechanism by which mannoprotein is able to regulate
this response remains unclear and is still under investiga-
tion. These results could open up new avenues in the
therapeutic strategy for treatment of inflammatory gut
processes induced by microbia.
Conclusions
Mannoprotein administration in a liquid diet seems to
protect intestinal tissue against S. typhimurium infection.
This protection seems to expressed as a lower pro-
inflammatory response and TLR5 downregulation in gut
epithelium, as well as by an inhibition of apoptosis. Nev-
ertheless, the molecular mechanism by which mannopro-
tein is able to regulate these responses remain unclear.
These results could open up new avenues in the use of
mannoproteins as prebiotics in the therapeutic strategy
for treatment of inflammatory gut processes induced by
microbia.
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